Minneapolis, Feb 25 — Yukon Partners (“Yukon”), a provider of junior capital for middle market private equity transactions, is pleased to announce it has partnered with The Riverside Company (“Riverside”) to support its investment in Western Botanicals (the “Company”).
Western Botanicals is a premier, full-service nutraceutical contract development and manufacturing organization serving more than 75 health and wellness brands across a diversified range of end use applications. With nearly three decades of experience, the Company offers end-to-end formulation, manufacturing, and packaging solutions across capsule, powder, and liquid formats from its 140,000+ square feet of FDA-registered, cGMP compliant facilities with organic and NSF-certifications. Western Botanicals combines deep industry expertise with a solutions-oriented, customer-centric culture, delivering products rooted in innovation, quality, and efficacy.
“We are excited to partner with the management team to build on the Company’s strong momentum,” said Brad Roberts, Co-Chief Investment Officer of Riverside’s Capital Appreciation strategy. “Together, we aim to support continued organic growth, expand product and format capabilities, and further establish Western Botanicals as a comprehensive solution for its customers.”
“We strive to partner with industry-leading nutraceutical brands through unmatched service, transparency, and quality,” said Western Botanicals CEO Don Shaver. “Our partnership with Riverside will allow us to continue this mission through organic growth while simultaneously executing an M&A strategy to build best-in-class capabilities.”
“The Company’s full-service capabilities, diversification, and well-invested facilities position Western Botanicals to continue driving strong growth,” said Dave Sampair, a Partner at Yukon. “We are excited to support the Western Botanicals team and look forward to another successful partnership with Riverside.”
Winston & Strawn LLP provided legal counsel to Yukon.